800-331-6634

February, 2019

Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness

By editor
February 20, 2019

Researchers have completed the first gene therapy procedure aimed at stoping age-related macular degeneration. Dr. Allen Ho commented, “What’s unique about this particular clinical trial is that they are trying gene therapy surgically delivered to the sub retinal space to try to modify the disease process of dry macular degeneration." Read the full article from...  read more


Diabetes and Eye Health - What to know about the disease’s association with vision loss

By editor
February 15, 2019

Diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the most frequent cause of new cases of blindness among adults ages 20 to 74. Dr. Omesh Gupta discusses how treatments have radically improved in the recent years. Read the full article here from AARP.


Testimony Tuesday

By editor
February 12, 2019
Upload: July 24, 2018

"Dr. Regillo cared for my dad at Mid Atlantic Retina’s Newtown Square office, and we very much appreciate his attention to my dad's well being - no one looks forward to a “shot in the eye ball”, but his administering of Dad’s care was superb. Upon seeing the article from The Inquirer, I reminded my...  read more


Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration

By editor
February 8, 2019

A study recently done out of the Mayo Clinic, looked into the risk of strokes due to anti-VEGF therapy for AMD. The study has found that there is no association between the two, and the use of anti-VEGF therapy is still the best option for patients with AMD. Dr. Carl Regillo added his own comment...  read more